{ "meta": { "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.", "terms": "https://open.fda.gov/terms/", "license": "https://open.fda.gov/license/", "last_updated": "2026-07-30", "results": { "skip": 0, "limit": 1, "total": 1 } }, "results": [ { "safetyreportid": "5155828-X", "transmissiondateformat": "102", "transmissiondate": "20070319", "serious": "1", "seriousnesshospitalization": "1", "seriousnessother": "1", "receivedateformat": "102", "receivedate": "20061120", "receiptdateformat": "102", "receiptdate": "20061120", "fulfillexpeditecriteria": "2", "primarysource": { "reportercountry": "UNITED STATES", "qualification": "2" }, "sender": { "senderorganization": "FDA-Public Use" }, "receiver": null, "patient": { "patientonsetage": "70", "patientonsetageunit": "801", "patientsex": "2", "reaction": [ { "reactionmeddrapt": "RENAL FAILURE ACUTE" } ], "drug": [ { "drugcharacterization": "1", "medicinalproduct": "TENOFOVIR", "drugdosagetext": "300 MG OD PO", "drugadministrationroute": "048", "drugindication": "HIV INFECTION" }, { "drugcharacterization": "2", "medicinalproduct": "MEPRON", "openfda": { "application_number": [ "NDA020500" ], "brand_name": [ "MEPRON" ], "generic_name": [ "ATOVAQUONE" ], "manufacturer_name": [ "GlaxoSmithKline LLC" ], "product_ndc": [ "0173-0547", "0173-0665" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "route": [ "ORAL" ], "substance_name": [ "ATOVAQUONE" ], "rxcui": [ "211947", "308429" ], "spl_id": [ "005bf875-7785-4b73-8c03-fa75737de8a9" ], "spl_set_id": [ "b426b6bf-f07e-4580-97ae-dfca1ddf5b8f" ], "package_ndc": [ "0173-0665-18", "0173-0547-00" ], "nui": [ "N0000175482", "N0000175485" ], "pharm_class_epc": [ "Antimalarial [EPC]", "Antiprotozoal [EPC]" ], "unii": [ "Y883P1Z2LT" ] } }, { "drugcharacterization": "2", "medicinalproduct": "EPOGEN", "openfda": { "application_number": [ "BLA103234" ], "brand_name": [ "EPOGEN" ], "generic_name": [ "EPOETIN ALFA" ], "manufacturer_name": [ "Amgen, Inc" ], "product_ndc": [ "55513-126", "55513-267", "55513-148", "55513-144", "55513-283", "55513-478" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "route": [ "INTRAVENOUS", "SUBCUTANEOUS" ], "substance_name": [ "EPOETIN" ], "rxcui": [ "205912", "205917", "205921", "205923", "212218", "239998", "239999", "240000", "240377", "241999", "1721684", "1721685" ], "spl_id": [ "bf994196-5149-4089-b1fc-c4f0cb8744b3" ], "spl_set_id": [ "1f2d0b28-9cc5-4523-80b8-637fdaf3f7a5" ], "package_ndc": [ "55513-126-01", "55513-126-10", "55513-126-20", "55513-267-01", "55513-267-10", "55513-267-20", "55513-148-01", "55513-148-10", "55513-148-20", "55513-144-01", "55513-144-10", "55513-144-20", "55513-283-01", "55513-283-10", "55513-283-20", "55513-478-01", "55513-478-10", "55513-478-20" ], "unii": [ "64FS3BFH5W" ] } }, { "drugcharacterization": "2", "medicinalproduct": "LEVETRECET" }, { "drugcharacterization": "2", "medicinalproduct": "LOPRESSOR", "openfda": { "application_number": [ "NDA219373", "NDA218698", "NDA017963" ], "brand_name": [ "LOPRESSOR" ], "generic_name": [ "METOPROLOL TARTRATE" ], "manufacturer_name": [ "VALIDUS PHARMACEUTICALS LLC", "Validus Pharmaceuticals LLC" ], "product_ndc": [ "30698-464", "30698-460", "30698-458", "30698-459" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "route": [ "ORAL" ], "substance_name": [ "METOPROLOL TARTRATE" ], "rxcui": [ "2712147", "2712152", "2723025", "2723027", "866511", "866513", "866514", "866516" ], "spl_id": [ "352cee93-db0d-1c05-e063-6294a90a7533", "494efa43-aa90-d6f4-e063-6294a90a11ac", "28c4fc69-5609-49ec-8fe5-4d7bc8f88288" ], "spl_set_id": [ "9f448171-9588-4a54-88b3-5d870060ce86", "b5f4fed2-369c-4808-a682-8a5b8cfdbb4f", "0283bc9d-6998-493a-824a-d4c85f704111" ], "package_ndc": [ "30698-464-30", "30698-464-31", "30698-460-03", "30698-460-01", "30698-460-10", "30698-458-01", "30698-459-01" ], "unii": [ "W5S57Y3A5L" ] } }, { "drugcharacterization": "2", "medicinalproduct": "REMERON", "openfda": { "application_number": [ "NDA020415" ], "brand_name": [ "REMERON" ], "generic_name": [ "MIRTAZAPINE" ], "manufacturer_name": [ "Organon LLC" ], "product_ndc": [ "78206-160", "78206-161", "78206-156", "78206-158", "78206-159" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "route": [ "ORAL" ], "substance_name": [ "MIRTAZAPINE" ], "rxcui": [ "211322", "211323", "283406", "283407", "283485", "311725", "314111", "752869", "752870", "752871" ], "spl_id": [ "8b121c7c-9bcd-4504-b789-3f551a0fe514" ], "spl_set_id": [ "98ad1917-a094-44f5-a28f-a64a8cfcd887" ], "package_ndc": [ "78206-160-01", "78206-161-01", "78206-156-99", "78206-156-01", "78206-158-99", "78206-158-01", "78206-159-99", "78206-159-01" ], "unii": [ "A051Q2099Q" ] } }, { "drugcharacterization": "2", "medicinalproduct": "ACCUPRIL" }, { "drugcharacterization": "2", "medicinalproduct": "LOXAPIN" }, { "drugcharacterization": "2", "medicinalproduct": "LASIX", "openfda": { "application_number": [ "NDA016273" ], "brand_name": [ "LASIX" ], "generic_name": [ "FUROSEMIDE" ], "manufacturer_name": [ "Validus Pharmaceuticals LLC" ], "product_ndc": [ "30698-060", "30698-067", "30698-066" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "route": [ "ORAL" ], "substance_name": [ "FUROSEMIDE" ], "rxcui": [ "197732", "200801", "200809", "205732", "310429", "313988" ], "spl_id": [ "4002943d-0b4b-4ff0-e063-6394a90ae63b" ], "spl_set_id": [ "2c9b4d8f-0770-482d-a9e6-9c616a440b1a" ], "package_ndc": [ "30698-067-01", "30698-067-10", "30698-060-01", "30698-060-10", "30698-060-50", "30698-066-05", "30698-066-50" ], "nui": [ "N0000175366", "N0000175590" ], "pharm_class_pe": [ "Increased Diuresis at Loop of Henle [PE]" ], "pharm_class_epc": [ "Loop Diuretic [EPC]" ], "unii": [ "7LXU5N7ZO5" ] } }, { "drugcharacterization": "2", "medicinalproduct": "FOSAMAX", "openfda": { "application_number": [ "NDA020560" ], "brand_name": [ "FOSAMAX" ], "generic_name": [ "ALENDRONATE SODIUM" ], "manufacturer_name": [ "Organon LLC" ], "product_ndc": [ "78206-135" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "route": [ "ORAL" ], "substance_name": [ "ALENDRONATE SODIUM" ], "rxcui": [ "904431", "904433" ], "spl_id": [ "1013aa0b-071e-46c4-8bed-207bb10ac2fd" ], "spl_set_id": [ "14e931fd-2c5f-4d90-b7db-5980706f4a56" ], "package_ndc": [ "78206-135-01" ], "unii": [ "2UY4M2U3RA" ] } }, { "drugcharacterization": "2", "medicinalproduct": "MARINOL", "openfda": { "application_number": [ "NDA018651" ], "brand_name": [ "MARINOL" ], "generic_name": [ "DRONABINOL" ], "manufacturer_name": [ "ThePharmaNetwork, LLC" ], "product_ndc": [ "53097-568", "53097-569", "53097-570", "53097-571", "53097-572", "53097-573" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "route": [ "ORAL" ], "substance_name": [ "DRONABINOL" ], "rxcui": [ "197634", "197635", "197636", "205641", "205642", "205645" ], "spl_id": [ "628f9609-6583-49be-be77-b64cfbc46fd7", "5ce802d5-e8ab-4cd1-9ba0-1f39f22ddd48" ], "spl_set_id": [ "628f9609-6583-49be-be77-b64cfbc46fd7", "d0efeeec-640d-43c3-8f0a-d31324a11c68" ], "package_ndc": [ "53097-568-60", "53097-569-60", "53097-570-60", "53097-571-60", "53097-572-60", "53097-573-60" ], "nui": [ "N0000175782", "M0003267" ], "pharm_class_epc": [ "Cannabinoid [EPC]" ], "pharm_class_cs": [ "Cannabinoids [CS]" ], "unii": [ "7J8897W37S" ] } } ] } } ] }